Marc Carrier

1989–2026 年に発表

別表記
Marc CARRIER
208
論文数
23,387
被引用数
76
h 指数
178
i10 指数

被引用数

Marc Carrier の年別被引用数1989 年: 被引用 4 件1991 年: 被引用 1 件2001 年: 被引用 1 件2002 年: 被引用 2 件2003 年: 被引用 2 件2005 年: 被引用 1 件2007 年: 被引用 1 件2008 年: 被引用 2 件2009 年: 被引用 4 件2010 年: 被引用 9 件2011 年: 被引用 19 件2012 年: 被引用 48 件2013 年: 被引用 49 件2014 年: 被引用 71 件2015 年: 被引用 68 件2016 年: 被引用 110 件2017 年: 被引用 90 件2018 年: 被引用 125 件2019 年: 被引用 617 件2020 年: 被引用 1,520 件2021 年: 被引用 1,290 件2022 年: 被引用 927 件2023 年: 被引用 557 件2024 年: 被引用 879 件2025 年: 被引用 271 件2026 年: 被引用 33 件1990 年は被引用が無いため表示していません1992〜2000 年は被引用が無いため表示していません2004 年は被引用が無いため表示していません2006 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,821 件、この内訳の 19.9%カナダ: 引用元論文 718 件、この内訳の 7.9%イタリア: 引用元論文 710 件、この内訳の 7.8%イギリス: 引用元論文 662 件、この内訳の 7.2%フランス: 引用元論文 451 件、この内訳の 4.9%オランダ: 引用元論文 401 件、この内訳の 4.4%ドイツ: 引用元論文 398 件、この内訳の 4.4%中国: 引用元論文 368 件、この内訳の 4%スペイン: 引用元論文 354 件、この内訳の 3.9%スイス: 引用元論文 249 件、この内訳の 2.7%オーストラリア: 引用元論文 189 件、この内訳の 2.1%日本: 引用元論文 167 件、この内訳の 1.8%
0%19.9%その他 29%

分野

  • Medicine89.5%
  • Biochemistry, Genetics and Molecular Biology3.5%
  • Health Professions1.7%
  • Immunology and Microbiology1.5%
  • Computer Science1.2%
  • Engineering0.8%
  • その他1.8%

トピック

  • Venous Thromboembolism Diagnosis and Management16.1%
  • COVID-19 Clinical Research Studies9.9%
  • Atrial Fibrillation Management and Outcomes6.4%
  • Long-Term Effects of COVID-194.5%
  • Heparin-Induced Thrombocytopenia and Thrombosis3.2%
  • Blood Coagulation and Thrombosis Mechanisms3.1%
  • その他56.8%

共著者

全論文

検索で開く
  1. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer

    著者: , , , , , , , , , , , , , , , - Blood Advances 2021 被引用: 849

  2. Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

    著者: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 被引用: 1,607

  3. Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 被引用: 847

  4. Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sam Schulman - JAMA Internal Medicine 2019 被引用: 501

  5. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John W. Eikelboom, Ido Weinberg, Sam Schulman, Marc Carrier, Gregory Piazza, Joshua A. Beckman, Philippe Gabríel Steg, Gregg W. Stone, Stephan Rosenkranz, Samuel Z. Goldhaber, Sahil A. Parikh, Manuel Monréal, Harlan M. Krumholz, Stavros Konstantinides, Jeffrey I. Weitz, Gregory Y.H. Lip - Journal of the American College of Cardiology 2020 被引用: 2,939

  6. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , - BMJ 2019 被引用: 313

  7. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 被引用: 439

  8. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizabeth Lorenzi, Scott Berry, Lindsay R. Berry, Aaron W. Aday, Farah Al-Beidh, Djillali Annane, Yaseen M. Arabi, Diptesh Aryal, Bihari, Shailesh, Abi Beane, Zahra Bhimani, Shailesh Bihari, Henny H. Billett, Lindsay Bond, Marc J. M. Bonten, Frank Brunkhorst, Meredith Buxton, Adrian Buzgau, Lana A. Castellucci, Sweta Chekuri, Jen‐Ting Chen, Allen Cheng, Tamta Chkhikvadze, Benjamin Coiffard, Todd W. Costantini, Sophie de Brouwer, Lennie Derde, Michelle A. Detry, Abhijit Duggal, Vladimír Džavík, Mark B. Effron, Lise J Estcourt, Brendan M. Everett, Dean Fergusson, Mark Fitzgerald, Robert Fowler, J.‐P. Galanaud, Benjamin Galen, Sheetal Gandotra, Sebastián García‐Madrona, Timothy D. Girard, Lucas C. Godoy, Andrew L. Goodman, Herman Goossens, Cameron Green, Yonatan Greenstein, Peter L Gross, Naomi M. Hamburg, Rashan Haniffa, George P. Hanna, Nicholas Hanna, Sheila M. Hegde, Carolyn M. Hendrickson, R. Duncan Hite, Alexander Hindenburg, Aluko A. Hope, James M Horowitz, Christopher M. Horvat, Kristin Hudock, Beverley J. Hunt, Mansoor Husain, Robert C. Hyzy, Vivek Iyer, Jeffrey R. Jacobson, Devachandran Jayakumar, Norma Keller, Akram Khan, Yuri Kim, Andrei Kindzelski, Andrew J. King ほか 78 名 - 2021 被引用: 589

  9. Role of direct oral anticoagulants in the treatment of cancer‐associated venous thromboembolism: guidance from the SSC of the ISTH

    著者: , , , , , , - Journal of Thrombosis and Haemostasis 2018 被引用: 434

  10. Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lisa Baumann Kreuziger, Abi Beane, Jeffrey S. Berger, Scott Berry, Lindsay R. Berry, Zahra Bhimani, Shailesh Bihari, Henny H. Billett, Lindsay Bond, Marc J. M. Bonten, Charlotte Bradbury, Maria M. Brooks, Frank Brunkhorst, Meredith Buxton, Adrian Buzgau, Marc Carrier, Lana A. Castelucci, Sweta Chekuri, Jen‐Ting Chen, Allen Cheng, Tamta Chkhikvadze, Benjamin Coiffard, Aira Contreras, Todd W. Costantini, Mary Cushman, Sophie de Brouwer, Lennie Derde, Michelle A. Detry, Abhijit Duggal, Vladimír Džavík, Mark B. Effron, Heather Eng, Jorge Escobedo, Lise J Estcourt, Brendan M. Everett, Micheal E. Farkough, Dean Fergusson, Mark Fitzgerald, Rob Fowler, Joshua D. Froess, Zhuxuan Fu, J.‐P. Galanaud, Benjamin Galen, Sheetal Gandotra, Timothy D. Girard, Lucus D. Godoy, Ewan C. Goligher, Michelle N. Gong, Andrew L. Goodman, Herman Goossens, Anthony Gordon, Cameron Green, Yonatan Greenstein, Peter L. Gross, Raquel Morillo Guerrero, Naomi M. Hamburg, Rashan Haniffa, George P. Hanna, Nicholas Hanna, Sheila M. Hedge, Carolyn M. Hendrickson, Alisa M. Higgins, Alexander Hindenburg, R. Duncan Hite, Judith S. Hochman, Aluko A. Hope, James M Horowitz, Christopher M. Horvat, Brett L. Houston, David T. Huang ほか 111 名 - JAMA 2023 被引用: 98

  11. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gloria Lim, Michael Fralick, Saskia Middeldorp, Agnes Lee, Fei Zuo, Bruno R. da Costa, Kevin E. Thorpe, Elnara Márcia Negri, Mary Cushman, Peter Jüni - BMJ 2021 被引用: 371

  12. Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care Systems

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 70

  13. Inflammasome Signaling, Thromboinflammation, and Venous Thromboembolism

    著者: , , , , , , - JACC Basic to Translational Science 2023 被引用: 62

  14. McMaster RARE‐Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Thrombosis and Haemostasis 2018 被引用: 140

  15. Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2023 被引用: 75

  16. Updates in the Incidence, Pathogenesis, and Management of Cancer and Venous Thromboembolism

    著者: , , , - Arteriosclerosis Thrombosis and Vascular Biology 2023 被引用: 68

  17. VTE Prophylaxis in Critically Ill Adults

    著者: , , , , , , , , , , , , , , , , , , - CHEST Journal 2021 被引用: 85

  18. Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous Thromboembolism

    著者: , , , , , , , , , , - Circulation 2012 被引用: 226

  19. Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study

    著者: , , , , , , , , , , , , , , , , , , , , , - Thrombosis and Haemostasis 2018 被引用: 214

  20. Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study

    著者: , , , , , , , , , , , - Thrombosis and Haemostasis 2018 被引用: 211

  21. Consensus Statements on the Risk, Prevention, and Treatment of Venous Thromboembolism in Inflammatory Bowel Disease: Canadian Association of Gastroenterology

    著者: , , , , , , , , , , , , , - Gastroenterology 2014 被引用: 347

  22. Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism

    著者: , , , , , , , , , , , , , , , , - Annals of Internal Medicine 2017 被引用: 142

  23. Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , - Blood Advances 2022 被引用: 58

  24. Management of cancer‐associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH

    著者: , , , , , , - Journal of Thrombosis and Haemostasis 2018 被引用: 211